Three physician-scientists named Dean’s Scholars
The Division of Physician-Scientists at the School of Medicine has selected three physicians for its third class of Dean’s Scholars.
$5.3 million grant supports research into lung cancer recurrence
A National Institutes of Health (NIH) grant to Washington University School of Medicine will support research into understanding lung cancer recurrence.
Medical school chosen for hematology training program
The Washington University School of Medicine is one of nine U.S. academic institutions selected by the American Society of Hematology for the organization’s Hematology-Focused Fellowship Training Program. Applications open in July.
Dao honored for advocacy efforts
The St. Louis Business Journal has recognized Anthony T. Dao, MD, an instructor in the Division of Hospital Medicine at the School of Medicine, with a Business of Pride Award.
Gut bacteria mine dietary fiber to release beneficial nutrients
A new study from Washington University School of Medicine found that the fiber byproducts of food production may be an untapped source of beneficial biomolecules that contribute to human health.
SPOT program for Jennings students receives grant
The School of Medicine has received $50,000 from Healthy Blue Missouri to support The SPOT (Supporting Positive Opportunities with Teens) at Jennings Senior High School.
OHMB recognizes Barch with Glass Brain Award
The Organization for Human Brain Mapping has awarded its Glass Brain Award to Deanna Barch, of Arts & Sciences and the School of Medicine, in recognition of her influential work on the function of the human brain.
Community-based rehab for disabilities works even in areas of conflict
A community-based rehabilitation program may be an effective way to provide services to people with disabilities even in places with conflict such as Afghanistan, finds a new study from the Brown School and the School of Medicine at Washington University.
Heiden receives award from cancer research group
Brendan Heiden, MD, a surgical resident and cardiothoracic surgery research fellow at Washington University School of Medicine, received the Harborside Endowed Merit Award from Conquer Cancer, the foundation of the American Society of Clinical Oncology.
Progression of diabetic kidney disease may be slowed with drug combinations
A mouse study led by Washington University School of Medicine suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.
View More Stories